advertisement
14 Costing studies; pharmacoeconomics (6)
Showing records 1 to 6
Display all abstracts in classification 14 Costing studies; pharmacoeconomics
Search within classification 14 Costing studies; pharmacoeconomics27124 A Canadian population-based study of vision problems: Assessing the significance of socioeconomic status
Perruccio AV; Badley EM; Trope GE
Canadian Journal of Ophthalmology 2010; 45: 477-483
27551 Modeling complex treatment strategies: construction and validation of a discrete event simulation model for glaucoma
Van Gestel A; Severens JL; Webers CA; Beckers HJ; Jansonius NM; Schouten JS
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2010; 13:4 358-367
27224 A comparative study on the efficacy, safety, and cost-effectiveness of bimatoprost/timolol and dorzolamide/timolol combinations in glaucoma patients
Jothi R; Ismail AM; Senthamarai R; Pal S
Indian Journal of Pharmacology 2010; 42: 362-365
27247 First-year treatment costs among new initiators of topical prostaglandin analog identified from November 2007 through April 2008
Schmier JK; Covert DW; Robin AL
Current Medical Research and Opinion 2010; 26: 2769-2777
27406 Effect of physician remuneration fees on glaucoma procedure rates in Canada
Buys YM; Austin PC; Campbell RJ
Journal of Glaucoma 2010;
27185 Setting priorities for comparative effectiveness research: A case study using primary open-angle glaucoma
Li T; Ervin A-M; Scherer R; Jampel H; Dickersin K
Ophthalmology 2010; 117: 1937-1945